Up0122 102 — Durham, North Carolina

Up0122 102 is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Up0122 102 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis.

Sponsors: UCB Biopharma SRL.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Up0122 102?

Up0122 102 has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Up0122 102 conducted?

Up0122 102 has 1 clinical trials on record, with 1 currently active. Their work covers Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis.

Is Up0122 102 accredited by Crixeo Health?

Up0122 102 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Up0122 102?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.